Superworth

Rallybio EPS RLYB

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
$7.92
Latest quarter, Q2 FY26
$7.53
Fiscal year 2025
−$1.60

Rallybio's earnings per share was $7.92 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was $7.53.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.60n/a
FY2024−$10.80n/a
FY2023−$14.72n/a
FY2022−$16.88n/a
FY2021−$14.96n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$7.53n/a$7.92
Q1 FY26−$1.46n/a−$1.37
Q4 FY25−$1.03n/a−$1.60
Q3 FY25$2.88n/a−$2.57
Q2 FY25−$1.76n/a−$7.53
Q1 FY25−$1.69n/a−$8.73
Q4 FY24−$2.00n/a−$10.80
Q3 FY24−$2.08n/a−$12.80
Q2 FY24−$2.96n/a−$14.32
Q1 FY24−$3.76n/a−$15.04
Q4 FY23−$4.00n/a−$14.72
Q3 FY23−$3.60n/a−$14.40

Against its peers

Companies in Drug Manufacturers - General nearest Rallybio's size, closest first, today.

CompanyEPS, 12 monthsGrowth
RLYBRallybio$7.92
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
ATNMActinium Pharmaceuticals$0.36
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
Peer median$0.65

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Rallybio

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.